Fifth Third Bancorp’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Fifth Third Bancorp’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$29.8K	Sell	450 -264	-37%	-$15.5K	﹤0.01%	3418
2026 Q1	$38.6K	Buy	+714	New	+$39.8K	﹤0.01%	3288
2016 Q1	–	Sell	-1,320	Closed	-$68K	–	2705
2015 Q4	$68K	Buy	1,320 +650	+97%	+$33.1K	﹤0.01%	1271
2015 Q3	$31K	Hold	670	–	–	﹤0.01%	1564
2015 Q2	$42K	Buy	+670	New	+$41.7K	﹤0.01%	1528
2014 Q4	–	Sell	-50	Closed	-$3K	–	2491
2014 Q3	$3K	Buy	+50	New	+$2.54K	﹤0.01%	2245

Other funds holding XPH

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

KWM

Kingsview Wealth Management Grants Pass, Oregon $8.25B AUM 24.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Evelyn Partners London $46.9B AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Fifth Third Bancorp's XPH Position: Q2 2026 in Review

Fifth Third Bancorp reduced its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 37% in Q2 2026, selling an estimated $15.5K and leaving 450 shares worth $29.8K. The position accounts for ﹤0.01% of the portfolio, ranked #3418.

Fifth Third Bancorp first reported a position in XPH in Q3 2014 and has held it in 6 quarters since. The position peaked at $68K in Q4 2015. 93 funds tracked by Wall St. Rank hold XPH as of Q2 2026.

Fifth Third Bancorp held 450 shares of State Street SPDR S&P Pharmaceuticals ETF worth $29.8K as of Q2 2026.
Fifth Third Bancorp sold 264 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2026, an estimated $15.5K.
State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Fifth Third Bancorp's portfolio in Q2 2026, its #3418 holding.
Fifth Third Bancorp first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q3 2014 and has held it in 6 quarters since.
Fifth Third Bancorp's State Street SPDR S&P Pharmaceuticals ETF position peaked at $68K in Q4 2015.
93 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2026.

Based on Fifth Third Bancorp's 13F filing for Q2 2026, filed 5 Aug 2026.